Medicine and Dentistry
Argon
14%
Bevacizumab
50%
Branch Retinal Vein Occlusion
51%
Caveolin 1
25%
Central Retinal Vein Occlusion
76%
Dexamethasone
50%
down Regulation
5%
Immunohistochemistry
14%
Implant
29%
Injection
5%
Interleukin 18
25%
Intravitreal Administration
7%
Intravitreal Implant
50%
Ischemia
6%
Mass Spectrum
8%
Mechanism of Action
6%
Peptidylprolyl Isomerase
5%
Platelet Derived Growth Factor Receptor
25%
Protein
42%
Proteomics
6%
Retina
19%
Retina Vein Occlusion
46%
Salt Water
5%
Serositis
8%
Tandem Mass Tag
8%
Therapeutic Procedure
15%
Transthyretin
25%
Upregulation
9%
Vasculotropin
8%
Vision
5%
Biochemistry, Genetics and Molecular Biology
Aflibercept
25%
Argon Laser
10%
Bevacizumab
25%
Clusterin
5%
Corticosteroid
5%
Dexamethasone
25%
down Regulation
5%
Experimental Model
7%
FKBP5
12%
Focal Adhesion
25%
Heat Shock Protein
5%
Isoform
5%
Label-Free Quantification
5%
Laminin
6%
Landrace Pig
5%
Liquid Chromatography Mass Spectrometry
5%
Liquid Chromatography Tandem Mass Spectrometry
5%
Mass Spectrometry
5%
N-Myc
5%
Nested Gene
5%
Osteopontin
5%
Protein
72%
Protein Characterization
25%
Proteome
7%
Proteome Analysis
25%
Proteomics
5%
Retinal Protein
6%
Sample
8%
Signal Transduction
25%
Tandem Mass Spectrometry
5%
Upregulation
35%
Vascular Endothelial Growth Factor
5%
Vimentin
5%
Western Blot
5%
Neuroscience
Angiography
7%
Bevacizumab
25%
Caveolin 1
25%
Central Retinal Vein
50%
Clusterin
5%
Dexamethasone
50%
Fluorescein
5%
Immunohistochemistry
12%
Interleukin 18
25%
Ischemia
6%
Mass Spectrometry
10%
Peptidylprolyl Isomerase
5%
Protein
58%
Proteome
9%
Proteomics
7%
Retinal Vein Occlusion
100%
Transthyretin
25%
Vimentin
5%